awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34086952-42459BA4-8D7A-452D-9AF1-51F6C5256AF8
Q34086952-42459BA4-8D7A-452D-9AF1-51F6C5256AF8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34086952-42459BA4-8D7A-452D-9AF1-51F6C5256AF8
The association of clinical outcome to first-line VEGF-targeted therapy with clinical outcome to second-line VEGF-targeted therapy in metastatic renal cell carcinoma patients
P2860
Q34086952-42459BA4-8D7A-452D-9AF1-51F6C5256AF8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34086952-42459BA4-8D7A-452D-9AF1-51F6C5256AF8
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5c83b124db07fb90067c887ef7932cfffbba8ee3
P2860
Phase III trial of bevacizumab plus interferon alfa versus interferon alfa monotherapy in patients with metastatic renal cell carcinoma: final results of CALGB 90206